Psychiatrische Praxis, Inhaltsverzeichnis Psychiatr Prax 2012; 39(02): 55-56DOI: 10.1055/s-0031-1298907 Editorial © Georg Thieme Verlag KG Stuttgart · New YorkWo ist der Fortschritt?Where is the Progress?Authors Institutsangaben Stefan Priebe Unit for Social and Community Psychiatry, Queen Mary University of London, Großbritannien Artikel empfehlen Abstract Volltext Referenzen Literatur 1 Bertelsen M, Jeppesen P, Petersen L et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 2008; 65: 762-771 2 Jones C, Hacker D, Meaden A et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2011; 4 CD00524 3 Kemp AS, Schooler NR, Kalili AH et al. What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?. Schizophr Bull 2010; 36: 504-509 4 Killaspy H, Bebbington P, Blizard P et al. The REACT study: randomised evaluation of assertive community treatment in north London. BMJ 2006; 332: 815-820 5 Burns T, Catty J, Watt H et al. International differences in home treatment for mental health problems: Results of a systematic review. Br J Psychiatry 2002; 181: 375-382 6 Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344: 1594-1602